We were founded by Cormorant Asset Management, LP, a leading life sciences focused investment firm.

About Cormorant

Founded in 2013, Cormorant Asset Management, LP (“Cormorant”) is a leading life sciences focused investment firm with approximately $2.5 billion assets under management. Cormorant invests in public and private innovative biotech, medtech and life science companies and supports them throughout their growth cycle. Cormorant is among the most active life-science crossover investors in terms of number of investments since 2015 with investments in over 100 privately held, life science-focused companies over this period.

Learn More

If you are interested to learn more about our work or would like to speak with us about partnership opportunities, please contact us.